Skip to content
BioCina
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Microbial
      • pDNA
      • mRNA
      • Warehouse
  • Our Services
    • Our Offerings
      • Microbial
      • pDNA
      • mRNA
    • Our Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Quality & Regulatory
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • Career Opportunities
      • Meet Our People
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
BioCina

Our Microbial Offering

Our team offers tremendous experience in microbial-based process development and clinical and commercial manufacturing, with most critical SME’s having an average tenure of 15+ years at the Adelaide site.

Our approach to process development emphasizes Quality by Design from the outset. We work closely with our clients to fully understand the concept product and establish a Quality Target Product Profile (QTPP). From the profile, we develop a process and a control strategy, to ensure our client’s product and process can be relied upon to be robust, stable, and suitably designed for future scale-up. Our manufacturing processes utilise fully enclosed, single-use systems for both buffers and process intermediates, which helps ensure sanitary conditions throughout manufacturing.

Our state-of-the-art facility offers development and manufacturing equipment to seamlessly scale-up from laboratory bench to commercial production scale.

BioCina’s knowledge and experience of partnering with our clients from pre-clinical development to commercial production ensures we are capable of navigating your journey to approval.

Microbial Manufacturing Equipment and Technology

BioCina’s state-of-the-art facility offers highest quality microbial cGMP cell banking and manufacturing. Our microbial equipment and technology includes:

  • Single-use fermentation up to 300 L and up to 500 L stainless steel fermentation
  • Midstream processing capability, including continuous flow centrifugation and high-pressure homogenization
  • Cell lysis technology
  • Refolding capacity up to 3,000 L
  • Downstream purification technology includes AKTA™ Isocratic and AKTA™ Gradient Chromatography skids and columns
  • UNIFLUX™ and Repligen Tangential Flow Filtration Systems

Services for Your Program Phase

Quality and Regulatory Services BioCina

Quality &
Regulatory

We successfully develop and manufacture your microbial product, from clinical stage through commercialisation, ensuring a robust and scalable process that maintains the highest product quality.

Read More
BioCina Process Development

Process
Development

A full service offering that can take you from gene sequence to Master Cell Bank and develop upstream and downstream processes, ready for scaling-up to our production fermenters and purification systems in the GMP suites.

Read More
Analytical Development BioCina

Analytical
Development

Development of new analytical methods and tech transfer of established methods, validation and extended product characterisation, and stability testing.

Read More

cGMP
Manufacturing

Featuring a hybrid manufacturing model with both stainless steel and single-use fermenter systems for DS production, in a single highly integrated facility.

Read More

Technology
Transfer

Our systematic technology transfer approach, includes thorough gap analysis and robust risk mitigation.

Read More

Our Expertise On Demand

Thought Leadership & Resources

BioCina and NovaCina Merger Bolsters Global CDMO Industry

January 13, 2025
|
Press Releases
BioCina Chief Executive Officer, Mark W. Womack BioCina Chief Executive Officer, Mark W. Womack [ADELAIDE, SOUTH...
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing

Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine

October 10, 2024
|
Press Releases
Adelaide, South Australia, October 10, 2024/-- BioCina Pty Ltd., a global end-to-end biologics Contract Development and...

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

September 24, 2024
|
Press Releases
Adelaide, South Australia, September 25, 2024/ — BioCina Pty Ltd., a global end-to-end biologics Contract Development...

We Want to Hear From You

Contact Us
  • About Us
    • Our Company
      • About BioCina
      • Our History
      • Mission and Vision
      • Executive Leadership
    • Facilities
      • Adelaide
      • Microbial
      • pDNA
      • mRNA
      • Warehouse
  • Our Services
    • Our Offerings
      • Microbial
      • pDNA
      • mRNA
    • Our Services
      • Technology Transfer
      • Process Development
      • Analytical Development
      • cGMP Manufacturing
      • Quality & Regulatory
  • News, Insights & Resources
    • News
      • Press Releases
      • Events
    • Thought Leadership
      • Research
      • White Papers
    • Resources
      • Videos
      • Fact Sheets
      • Case Studies
  • Careers
    • Join Our Team
      • Career Opportunities
      • Meet Our People
  • Policies
    • Our Policies
      • Quality Policy
      • EHS Policy
      • Privacy Policy
  • Contact Us
OUR VISION

To be the most client-centric and reliable Biologics CDMO, accelerating therapies to market and enriching the lives of all stakeholders.

OUR MISSION

We provide everything clients value the most.
We keep our commitments through unrivaled quality and industry-leading on-time and in-full delivery, every step of the way.

About Us

  • Our Company
  • About BioCina
  • Our History
  • Mission and Vision
  • Executive Leadership

  • Facilities
  • Adelaide
  • Microbial
  • pDNA
  • mRNA
  • Warehouse
Our Services

  • Our Offerings
  • Microbial
  • pDNA
  • mRNA

  • Our Services
  • Technology Transfer
  • Process Development
  • Analytical Development
  • cGMP Manufacturing
  • Quality & Regulatory
News, Insights & Resources

  • News
  • Press Releases
  • Events

  • Thought Leadership
  • Research
  • White Papers

  • Resources
  • Videos
  • Facts Sheets
  • Case Studies
Careers

  • Join Our Team
  • Career Opportunities
  • Meet Our People
Policies

  • Our Policies
  • Quality Policy
  • EHS Policy
  • Privacy Policy
Contact Us

© 2025 BioCina. All Rights Reserved.